The US Centers for Medicare and Medicaid Services aims to withdraw the Trump administration's plan for a demonstration project to lower Medicare spending on high-cost Part B drugs by matching reimbursement rates to the lowest price found in certain countries abroad, also known as the "most favored nation" policy.
The move comes less than a month before the Biden administration is slated to outline some of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?